APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Protein Glutamine Gamma Glutamyltransferase 2

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Protein Glutamine Gamma Glutamyltransferase 2 Market Analysis and Forecast 2026-2032

Report ID 174029550219 December 2025194 pages

Choose your research edition.

Industry ResearchProtein Glutamine Gamma Glutamyltransferase 2 Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Protein Glutamine Gamma Glutamyltransferase 2 Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Protein Glutamine Gamma Glutamyltransferase 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Protein Glutamine Gamma Glutamyltransferase 2 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Protein Glutamine Gamma Glutamyltransferase 2 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Protein Glutamine Gamma Glutamyltransferase 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Protein Glutamine Gamma Glutamyltransferase 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Protein Glutamine Gamma Glutamyltransferase 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Protein Glutamine Gamma Glutamyltransferase 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Protein Glutamine Gamma Glutamyltransferase 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Protein Glutamine Gamma Glutamyltransferase 2 include Catabasis Pharmaceuticals Inc and Zedira GmbH etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Protein Glutamine Gamma Glutamyltransferase 2, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Protein Glutamine Gamma Glutamyltransferase 2, also provides the revenue of main regions and countries. Of the upcoming market potential for Protein Glutamine Gamma Glutamyltransferase 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Protein Glutamine Gamma Glutamyltransferase 2 revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Protein Glutamine Gamma Glutamyltransferase 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Protein Glutamine Gamma Glutamyltransferase 2 revenue, projected growth trends, production technology, application and end-user industry.

Protein Glutamine Gamma Glutamyltransferase 2 Segment by Company

Catabasis Pharmaceuticals Inc

Zedira GmbH

Protein Glutamine Gamma Glutamyltransferase 2 Segment by Type

ZED-1227

ERW-1041E

CAT-5571

Others

Protein Glutamine Gamma Glutamyltransferase 2 Segment by Application

Hospital

Clinic

Others

Protein Glutamine Gamma Glutamyltransferase 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Protein Glutamine Gamma Glutamyltransferase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Protein Glutamine Gamma Glutamyltransferase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Protein Glutamine Gamma Glutamyltransferase 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Protein Glutamine Gamma Glutamyltransferase 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Protein Glutamine Gamma Glutamyltransferase 2 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Protein Glutamine Gamma Glutamyltransferase 2 revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ZED-1227 Major Player Table 3. ERW-1041E Major Player Table 4. CAT-5571 Major Player Table 5. Others Major Player Table 6. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Clinic Major Player Table 9. Others Major Player Table 10. Protein Glutamine Gamma Glutamyltransferase 2 Industry Trends Table 11. Protein Glutamine Gamma Glutamyltransferase 2 Industry Drivers Table 12. Protein Glutamine Gamma Glutamyltransferase 2 Industry Opportunities and Challenges Table 13. Protein Glutamine Gamma Glutamyltransferase 2 Industry Restraints Table 14. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Share by Region (2021-2026) Table 17. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Share by Region (2027-2032) Table 19. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Players (2021-2026) Table 21. Global Protein Glutamine Gamma Glutamyltransferase 2 Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Protein Glutamine Gamma Glutamyltransferase 2 Key Players Headquarters & Area Served Table 23. Global Protein Glutamine Gamma Glutamyltransferase 2 Players, Product Type & Application Table 24. Global Protein Glutamine Gamma Glutamyltransferase 2 Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Protein Glutamine Gamma Glutamyltransferase 2 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Type (2021-2026) Table 31. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Type (2027-2032) Table 32. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Application (2021-2026) Table 36. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Application (2027-2032) Table 37. Catabasis Pharmaceuticals Inc Company Information Table 38. Catabasis Pharmaceuticals Inc Business Overview Table 39. Catabasis Pharmaceuticals Inc Protein Glutamine Gamma Glutamyltransferase 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Catabasis Pharmaceuticals Inc Protein Glutamine Gamma Glutamyltransferase 2 Product Portfolio Table 41. Catabasis Pharmaceuticals Inc Recent Development Table 42. Zedira GmbH Company Information Table 43. Zedira GmbH Business Overview Table 44. Zedira GmbH Protein Glutamine Gamma Glutamyltransferase 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Zedira GmbH Protein Glutamine Gamma Glutamyltransferase 2 Product Portfolio Table 46. Zedira GmbH Recent Development Table 47. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026) & (US$ Million) Table 48. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032) & (US$ Million) Table 49. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026) & (US$ Million) Table 50. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032) & (US$ Million) Table 51. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 52. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021-2026) & (US$ Million) Table 53. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (US$ Million) & (2027-2032) Table 54. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026) & (US$ Million) Table 55. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032) & (US$ Million) Table 56. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026) & (US$ Million) Table 57. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032) & (US$ Million) Table 58. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 59. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021-2026) & (US$ Million) Table 60. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (US$ Million) & (2027-2032) Table 61. China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026) & (US$ Million) Table 62. China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032) & (US$ Million) Table 63. China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026) & (US$ Million) Table 64. China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032) & (US$ Million) Table 65. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026) & (US$ Million) Table 66. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032) & (US$ Million) Table 67. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026) & (US$ Million) Table 68. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032) & (US$ Million) Table 69. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 70. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Region (US$ Million) & (2021-2026) Table 71. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Region (US$ Million) & (2027-2032) Table 72. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026) & (US$ Million) Table 73. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032) & (US$ Million) Table 74. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026) & (US$ Million) Table 75. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032) & (US$ Million) Table 76. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021-2026) & (US$ Million) Table 78. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (US$ Million) & (2027-2032) Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Protein Glutamine Gamma Glutamyltransferase 2 Image Figure 2. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. ZED-1227 Image Figure 5. ERW-1041E Image Figure 6. CAT-5571 Image Figure 7. Others Image Figure 8. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size (US$ Million) & (2021-2032) Figure 14. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Protein Glutamine Gamma Glutamyltransferase 2 Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Type (2021-2032) Figure 21. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Application (2021-2032) Figure 24. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032) Figure 26. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032) Figure 27. North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Country (2021-2032) Figure 28. United States Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032) Figure 33. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032) Figure 34. Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Country (2021-2032) Figure 35. Germany Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032) Figure 45. China Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032) Figure 46. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032) Figure 48. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032) Figure 49. Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Region (2021-2032) Figure 50. Japan Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032) Figure 58. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032) Figure 59. SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Country (2021-2032) Figure 60. Brazil Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Protein Glutamine Gamma Glutamyltransferase 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • ZED-1227
  • ERW-1041E
  • CAT-5571
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Catabasis Pharmaceuticals Inc
  • Zedira GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Protein Glutamine Gamma Glutamyltransferase 2 Market by Type
  3. 1.2.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ZED-1227
  5. 1.2.3 ERW-1041E
  6. 1.2.4 CAT-5571
  7. 1.2.5 Others
  8. 1.3 Protein Glutamine Gamma Glutamyltransferase 2 Market by Application
  9. 1.3.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Protein Glutamine Gamma Glutamyltransferase 2 Market Dynamics
  1. 2.1 Protein Glutamine Gamma Glutamyltransferase 2 Industry Trends
  2. 2.2 Protein Glutamine Gamma Glutamyltransferase 2 Industry Drivers
  3. 2.3 Protein Glutamine Gamma Glutamyltransferase 2 Industry Opportunities and Challenges
  4. 2.4 Protein Glutamine Gamma Glutamyltransferase 2 Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Perspective (2021-2032)
  2. 3.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Growth Trends by Region
  3. 3.2.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size by Region (2021-2026)
  5. 3.2.3 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Players
  2. 4.1.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Players (2021-2026)
  3. 4.1.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Protein Glutamine Gamma Glutamyltransferase 2 Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Protein Glutamine Gamma Glutamyltransferase 2 Key Players Headquarters & Area Served
  7. 4.4 Global Protein Glutamine Gamma Glutamyltransferase 2 Players, Product Type & Application
  8. 4.5 Global Protein Glutamine Gamma Glutamyltransferase 2 Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Market CR5 and HHI
  11. 4.6.3 2025 Protein Glutamine Gamma Glutamyltransferase 2 Tier 1, Tier 2, and Tier 3
5 Protein Glutamine Gamma Glutamyltransferase 2 Market Size by Type
  1. 5.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2032)
  3. 5.3 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Type (2021-2032)
6 Protein Glutamine Gamma Glutamyltransferase 2 Market Size by Application
  1. 6.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2032)
  3. 6.3 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Catabasis Pharmaceuticals Inc
  2. 7.1.1 Catabasis Pharmaceuticals Inc Company Information
  3. 7.1.2 Catabasis Pharmaceuticals Inc Business Overview
  4. 7.1.3 Catabasis Pharmaceuticals Inc Protein Glutamine Gamma Glutamyltransferase 2 Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Catabasis Pharmaceuticals Inc Protein Glutamine Gamma Glutamyltransferase 2 Product Portfolio
  6. 7.1.5 Catabasis Pharmaceuticals Inc Recent Developments
  7. 7.2 Zedira GmbH
  8. 7.2.1 Zedira GmbH Company Information
  9. 7.2.2 Zedira GmbH Business Overview
  10. 7.2.3 Zedira GmbH Protein Glutamine Gamma Glutamyltransferase 2 Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zedira GmbH Protein Glutamine Gamma Glutamyltransferase 2 Product Portfolio
  12. 7.2.5 Zedira GmbH Recent Developments
8 North America
  1. 8.1 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue (2021-2032)
  2. 8.2 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2032)
  3. 8.2.1 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026)
  4. 8.2.2 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032)
  5. 8.3 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032)
  6. 8.4 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2032)
  7. 8.4.1 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026)
  8. 8.4.2 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032)
  9. 8.5 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032)
  10. 8.6 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country
  11. 8.6.1 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021-2026)
  13. 8.6.3 North America Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue (2021-2032)
  2. 9.2 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2032)
  3. 9.2.1 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026)
  4. 9.2.2 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032)
  5. 9.3 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032)
  6. 9.4 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2032)
  7. 9.4.1 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026)
  8. 9.4.2 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032)
  9. 9.5 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032)
  10. 9.6 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country
  11. 9.6.1 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021-2026)
  13. 9.6.3 Europe Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Protein Glutamine Gamma Glutamyltransferase 2 Revenue (2021-2032)
  2. 10.2 China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2032)
  3. 10.2.1 China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026)
  4. 10.2.2 China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032)
  5. 10.3 China Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032)
  6. 10.4 China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2032)
  7. 10.4.1 China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026)
  8. 10.4.2 China Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032)
  9. 10.5 China Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue (2021-2032)
  2. 11.2 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2032)
  3. 11.2.1 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026)
  4. 11.2.2 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032)
  5. 11.3 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032)
  6. 11.4 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2032)
  7. 11.4.1 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026)
  8. 11.4.2 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032)
  9. 11.5 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032)
  10. 11.6 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country
  11. 11.6.1 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021-2026)
  13. 11.6.3 Asia Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue (2021-2032)
  2. 12.2 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Type (2027-2032)
  5. 12.3 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Application (2027-2032)
  9. 12.5 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country
  11. 12.6.1 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst